Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:J.J._Finkelstein
|
| gptkbp:collaboratesWith |
GtreeBNT
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
gptkb:cardiovascular_disease
wound healing neurodegenerative diseases development of therapeutic peptides ocular disorders |
| gptkbp:foundedYear |
1982
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Thymosin_beta-4_(Tβ4)
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:RGRX
|
| gptkbp:website |
https://www.regenerx.com/
|
| gptkbp:bfsParent |
gptkb:Tommy_Thompson
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
RegeneRx Biopharmaceuticals
|